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The complicated relationship between weight loss and health-related
quality of life: Satisfaction not guaranteedThe global burden of obesity continues to increase at an
alarming rate. Kelly et al.1 estimated that 33% of the world’s
adult population was overweight or obesity in 2005, and, if the
trends persist, by 2030 up to 58% of the world’s adult pop-
ulation could be either overweight or obese. Obesity is a well-
known risk factor for hypertension, hyperlipidemia, type 2
diabetes, coronary heart disease, and some cancers.2 More-
over, obesity has a substantially detrimental impact on health-
related quality of life (HrQoL).3 HrQoL is a self-reported
outcome, coming directly from affected persons concerning
their life, health conditions, and treatments.4 This distinct set
of concepts is related to an individual’s feelings of well-being
and perception of physical, emotional, and social functioning,
which reflects the subjective evaluation and reaction to
a health condition by the person.3,4 The majority of published
studies indicate that there appears to be a “dose-response”
relationship between body mass index and the degree of
HrQoL impairment, and that obesity-related decrements on
HrQoL tend to be most pronounced on physical domains of
functioning.3
In this issue of the Journal, Pan et al.5 reported the
changes of HrQoL outcomes among the participants of
a weight loss trial. They recruited 67 participants with body
mass index 27 kg/m2 into a 3-month weight loss program.
Among them, 57% participants finished the program. Two
third of the completers were able to reduce weight for more
than 5%, and their HrQoL outcomes, measured by the
WHOQOL-BREF questionnaire (a general HrQoL measure),
improved after weight loss. Meanwhile, 13 subjects could not
attain the 5% weight-loss goal in the study and did not show
significant improvements in HrQoL outcomes. Although this
is a pilot study with a small number of subjects, it raises
several issues that are worthy of discussions. First, HrQoL
may be assessed by using generic measures that are appli-
cable to any population or measure specific to the disease
under study. Scores of generic measures may be compared
with norms of general populations and across diseases.
Disease-specific measures contain items relevance to the
disease and may be more sensitive to small changes over time
or small differences between groups than generic measures.
Kolotkin6 and colleagues compared HrQoL data from 9261726-4901/$ - see front matter Copyright  2011 Elsevier Taiwan LLC and the C
doi:10.1016/j.jcma.2011.01.033participants in a 1-year weight loss study and found that the
results of two generic measures (the SF-36 and the EQ-5D)
were inconsistent with each other. Maciejewski et al.4
reviewed the effects of weight-loss interventions on HrQoL
in 34 randomized controlled trials and identified that even
when the same generic measure was used, the treatment
effects were shown for some, but not all, domains, and these
domains varied across studies. They suggested that obesity-
specific measures were more likely to demonstrate improve-
ments in response to treatment than generic measures.4
However, Duval et al.7 examined 11 obesity-specific quality
of life questionnaires and outlined the purpose and psycho-
metric properties of each measure. While 9 of the question-
naires were developed specially as instruments for clinical
trials, only two of them (IWQOL, OP-Scale) could exhibit
responsiveness in randomized controlled trials.7 Because
HrQoL outcomes vary with the types of measures, Kolotkin
et al.6 proposed using an assessment battery to measure
HrQoL changes in weight loss studies. Nevertheless, there is
no consensus on what is the best approach in terms of a “gold
standard” assessment battery. Apparently, adding a new
generic measure such as the WHOQOL-BREF questionnaire
into the research tool box does not help much in solving the
above problems.
Second, to what extent of weight loss can benefit the HrQoL
for obese subjects has been a major field of research. Many
health authorities imply that a weight-change threshold exists
for weight-loss interventions.8 Leading organizations recom-
mend that weight loss of 5e10% is associated with benefits
across a wide range of health outcomes and is considered
clinically relevant.8 Samsa et al.9 analyzed data from 555
subjects to determine whether the improvement of HrQoL was
noticeable for subjects achieving 5e10% weight reduction.
They found that weight loss of 5e10% was significantly
associated with a 10-unit improvement in the IWQOL total
subscale. Wu and colleagues10 have performed a similar study
in obese Chinese subjects. They described that subjects with
weight loss 15% had the greatest improvements in SF-36
scores whereas no changes in SF-36 scores were found in
those with weight loss <5%. The investigators concluded that
weight loss above 5% of baseline was necessary to showhinese Medical Association. All rights reserved.
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interventions. The current study also demonstrated that there
were no improvements in HrQoL among the completers who
lost weight <5%.5 It seems to us that 5% weight loss is
a threshold for improvements in HrQoL across different ethnic
groups.
Finally, several researchers recently promote the notion
that a lifestyle-modification program characterized by an
increase in physical activity and a balanced diet can reduce the
risk of obesity-related comorbid conditions despite minimal or
no weight change.8 Ross and Bradshaw8 summarized that the
benefits of such an approach include appreciable reductions in
abdominal obesity, improvements in insulin sensitivity, and
increases in both skeletal muscle mass and cardiorespiratory
fitness. In Pan’s study,5 we noted that the completers with
weight loss <5% still experienced significant reductions in
waist circumference and diastolic blood pressure during the
3-month intervention. Although it is not clear presently how
these small changes in cardiovascular risk factors being
translated into hard clinical outcomes, it appears that it is time
for a reappraisal of the use of weight loss as the only criteria
for successful obesity management.
In conclusion, obesity is a major public health problem.
The effective treatment of obesity should look beyond weight
loss, addressing both the medical burden and the outcomes of
HrQoL. Health care providers and the obese person should
recognize the clinical relevance of 5e10% weight loss in
health promotion and in improvements of HrQoL. It is
important for clinicians to encourage positive lifestyle modi-
fications in their patients continuously because the obesity
treatment is a lifelong task.Chii-Min Hwu
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